Wade, Derick T, Makela, Petra, Robson, Philip, House, Heather i inni. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. „Multiple Sclerosis”. 10 (4), s. 434-441, 2004. DOI: 10.1191/1352458504ms1082oa. PMID: 15327042.
Wade, D T, Makela, P M, House, H, Bateman, C i inni. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. „Multiple Sclerosis”. 12 (5), s. 639 -645, 2006. DOI: 10.1177/1352458505070618. PMID: 17086911.
Wade, Derick T, Robson, Philip, House, Heather, Makela, Petra i inni. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. „Clinical Rehabilitation”. 17 (1), s. 21 -29, 2003. DOI: 10.1191/0269215503cr581oa. PMID: 12617376.
Dorota Olszewska, Michał Kidawa: Sativex – lek z marihuany. Krajowe Biuro Do Spraw Przeciwdziałania Narkomanii, 2013-02-26. [dostęp 2014-07-30].
nih.gov
ncbi.nlm.nih.gov
Wade, Derick T, Makela, Petra, Robson, Philip, House, Heather i inni. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. „Multiple Sclerosis”. 10 (4), s. 434-441, 2004. DOI: 10.1191/1352458504ms1082oa. PMID: 15327042.
Wade, D T, Makela, P M, House, H, Bateman, C i inni. Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. „Multiple Sclerosis”. 12 (5), s. 639 -645, 2006. DOI: 10.1177/1352458505070618. PMID: 17086911.
Wade, Derick T, Robson, Philip, House, Heather, Makela, Petra i inni. A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms. „Clinical Rehabilitation”. 17 (1), s. 21 -29, 2003. DOI: 10.1191/0269215503cr581oa. PMID: 12617376.